Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856843 · ClinicalTrials.gov registry record · Phase 3
BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
A Phase 3 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 136
- Enrollment target
NCT00856843 is a Phase 3 study that has completed, run by Braintree Laboratories. The registered enrollment target is 136 participants.
The verdict
NCT00856843, a Phase 3 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 136 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of BLI800 vs an FDA approved bowel preparation before colonoscopic examination in adult subjects.
Interventions
- DRUG Polyethylene glycol 3350 based bowel preparation
- DRUG BLI800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2009-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00856843
The ClinicalTrials.gov registry entry for NCT00856843 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Polyethylene glycol 3350 based bowel preparation is the first listed.
NCT00856843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00856843 about?
NCT00856843 is a clinical study titled "BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects". To evaluate the safety and efficacy of BLI800 vs an FDA approved bowel preparation before colonoscopic examination in adult subjects.
What is the current status of trial NCT00856843?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 136 participants. The study started on 2009-02.
What interventions are being tested in trial NCT00856843?
The interventions under investigation include: Polyethylene glycol 3350 based bowel preparation (DRUG), BLI800 (DRUG).
Who is sponsoring clinical trial NCT00856843?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.